Skip to content
Clinical Trials – home

Sante Atlantique

Research site

France Avenue Claude Bernard, 44800 Saint-Herblain, France

  • 5 trials recruiting
  • Metabolic dysfunction-associated steatohepatitis · Back pain · Colorectal cancer
  • Adult patients

About Specializations

Sante Atlantique in Saint-Herblain, France specialises in clinical trials of conditions such as Metabolic dysfunction-associated steatohepatitis, Back pain, Colorectal cancer, Crohn's disease, and other specialisations. This site conducts important research.

Main research areas of the site

Digestive System Diseases

At Sante Atlantique, clinical research in digestive system diseases focuses on Crohn's disease and colorectal cancer, with studies aimed at improving treatment response and surgical outcomes.

  • Testing whether a new therapeutic strategy can improve disease control in Crohn's disease after loss of response to current treatment.
  • Evaluating ways to reduce complications in colorectal surgery by better assessing tissue perfusion during the operation.
  • Supporting more effective care for patients with inflammatory bowel disease and cancer-related digestive conditions.

This area combines medical treatment research with surgical innovation, reflecting a strong interest in both long-term disease management and safer procedures.

Musculoskeletal Diseases

The anesthésie orthopédie department is also studying musculoskeletal diseases, especially acute low back pain, with research focused on better pain relief for recent lumbago.

  • Assessing whether targeted anesthetic blocks can ease pain from muscle contractures in the first days after onset.
  • Exploring improved symptom control for people with acute lumbar pain.
  • Advancing practical approaches to short-term pain management in common back disorders.

This work is centered on improving comfort and recovery through more effective pain management strategies.

Neoplasms

Research in neoplasms at this site includes studies related to colorectal cancer, with a focus on making surgery safer and reducing postoperative complications.

  • Studying whether intraoperative imaging can help surgeons better evaluate blood flow in bowel tissue.
  • Aiming to lower the risk of anastomotic leakage after colorectal surgery.
  • Supporting efforts to improve surgical outcomes for patients with cancer of the colon and rectum.

These trials reflect a strong interest in surgical innovation and in improving the safety of cancer treatment.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Avenue Claude Bernard44800 Saint-HerblainFrance
Recruiting now
5 trials
Conditions studied
4

More sites in Saint-HerblainFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

7 clinical trials

A Phase 3 Study of Efimosfermin Alfa to Assess Safety and Tolerability in Adults with F2‑F3 Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:Glaxosmithkline Research & Development Limited

Safety and Efficacy of Efimosfermin Alfa in Participants with Biopsy‑Confirmed F2‑ or F3‑Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:Glaxosmithkline Research & Development Limited

Study on Indocyanine Green for Reducing Leakage in Colorectal Cancer Surgery Patients

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Indocyanine Green
  • Sponsor:Centre Hospitalier Regional Universitaire

Back pain

Recruiting

Study of Ropivacaine and Dexamethasone Injection for Acute Low Back Pain Relief: Testing the Effectiveness of Erector Spinae Muscle Block

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone Phosphate
  • Sponsor:Sante Atlantique

Crohn's disease

Recruiting

Study Comparing Vedolizumab and Adalimumab for Crohn's Disease Patients Who No Longer Respond to Adalimumab

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:Centre Hospitalier Universitaire De Saint Etienne

Safety and efficacy of efimosfermin alfa versus placebo in adults with compensated cirrhosis (stage F4) due to MASH

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:Glaxosmithkline Research & Development Limited

Study of efimosfermin alfa versus placebo in adults with compensated cirrhosis from metabolic dysfunction-associated steatohepatitis (MASH)

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:Glaxosmithkline Research & Development Limited
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.